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Domain swapped protein dimers consist of a swapped domain linked by a hinge
loop. They have been proposed as a means of achieving larger assemblies
potentially contributing to biological cellular activity or conferring disease.
Here we present a crystal structure of a C-terminal domain swapped dimer in
yeast iso-1-cytochrome c. In this structure the C-terminal alpha helix from
one monomer positions itself in the native position of the opposite monomer
and vice versa. The highly dynamic heme crevice loop, the most highly
conserved portion of the cytochrome c sequence, spans the gap acting as the
hinge loop. Interestingly, conversion of the heme crevice loop to the hinge
loop results in a loss of the native Met80-heme ligation. This produces an
open heme coordination site on each subunit of the dimer. As cytochrome c re-
quires an open heme coordination site to act as a peroxidase, to oxidize cardi-
olipin and initiate the intrinsic apoptotic pathway, this dimer structure could
potentially be a structure particularly suited to function in oxidizing cardiolipin.
In fact, a recently reported C-terminal domain swapped dimer of horse cyto-
chrome c demonstrates increased peroxidase activity relative to the monomer.
Although the yeast and horse dimer are similar, the hinge loop orientations
differ. The hinge loop is two residues longer in the yeast dimer resulting in
an increased distance between the heme groups and an altered angle of the
hinge loops relative to the horse cytochrome c dimer. Even though they contain
similar structure and sequence, the domain swapped yeast iso-1-cytochrome c
dimer demonstrates decreased stability compared to the horse cytochrome c
dimer.
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GlbN, the ‘‘truncated’’ hemoglobin from Synechocystis sp. PCC 6803, coordi-
nates the heme iron with His46 (E10, distal) and His70 (F8, proximal).
Displacement of His E10 by an exogenous ligand (e.g., cyanide in the ferric
state) drives a significant conformational change allowing Tyr22 (B10),
Gln43 (E7) and Gln47 (E11) to establish a hydrogen bond network stabilizing
the distal ligand.
THB1, a closely related hemoglobin from Chlamydomonas reinhardtii, also
binds cyanide and forms the same network of interactions. However, in the
absence of an exogenous ligand, the neutral amino group of Lys53 (E10)
coordinates the heme iron on the distal side [1]. Because of the importance
of the coordination scheme in controlling the reactivity of heme proteins,
the flexibility of the truncated hemoglobin fold, and the rarity of lysine coor-
dination, we explored the ability of GlbN to use lysine at position E10 as an
axial ligand. The His46Lys replacement yielded a protein with UV-Vis and
NMR spectra similar to those of His46Leu and comparable pH response, sug-
gesting that GlbN does not accommodate lysine coordination at position E10.
However, the spectra were incompatible with water coordination and sug-
gested that in the ferric state these variants were low-spin endogenously hex-
acoordinate complexes. We performed amino acid replacements within the
distal H-bond network to characterize the perturbed heme environment and
ligand sets. A combination of pH titrations and NMR experiments illustrates
the delicate balance of interactions governing the heme pocket conformation
of GlbN.
[1] Johnson et al. (2014) Biochemistry 53:4573
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The inhibition of the first calcium and integrin binding protein, CIB1 has been
observed to interfere with signaling in breast-cancer cells by inducing non-
apoptotic cancer cell death without harming healthy cells. This has led to a
push for creating targeted therapy drugs which inhibit the CIB1 protein. While
inhibiting CIB1 kills cancer cells, inhibiting the second protein, CIB2, could
lead to hearing loss or deafness. Since CIB2 and CIB1 share similar sequences,I wanted to determine whether CIB2 could be inhibited by the potential targeted
therapy drugs used to inhibit CIB1. Since no structure for CIB2 exists, I first
created a homology model for the protein by threading the sequence for
CIB2 onto the 2LM5 PDB structure of CIB1. This model was relaxed using
Discrete Molecular Dynamics and analyzed for stability. Maestro and Peptide
Docking simulations were then used to examine the model for druggable sites
and association sites. The druggable sites were used for virtual screening with
MedusaDock, where the results for CIB2 were to be compared to a previous
virtual screening done for CIB1. Any drugs that were found to bind to both pro-
teins would be excluded as targeted therapy candidates. By analyzing the model
I was able to determine that CIB2 has one bipartite druggable site and two pep-
tide association sites. Since the peptide association sites and druggable site on
CIB2 were different in location and composition to the peptide and druggable
site on CIB1, I concluded that the targeted therapy drugs created for CIB1 will
have no effect on the functioning of CIB2. In the future, my lab intends to deter-
mine which association site on CIB2 corresponds to the actual peptide-binding
site, as well as analyze the virtual screening results and experimentally validate
the data from our simulations.
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Cardiac Troponin C (TnC) is a Ca2þ-binding protein and plays an important
role in regulation of muscle contraction. Mutations in cTnC are implicated
in phenotypic characteristics known as hypertrophic and dilated cardiomyop-
athy (HCM and DCM, respectively). However, the structural mechanisms un-
derlying cardiac dysfunction are unknown. The main goal of this work is to
investigate changes in stability and dynamics of seven cTnC variants (A8V,
D145E, C84Y and A31S related to HCM; and Y5H, M103I and I148V
related to DCM) using an ensemble of thermodynamic and structural ap-
proaches. Ca2þ-titrations monitored by bis-ANS fluorescence revealed that
D145E, A31S and all mutations related with DCM decreased the Ca2þ-
induced hydrophobic exposure, while C84Y substantially enhance it by the
N-domain exposure compared to WT. Thermostability monitored by circular
dichroism revealed similar melting temperatures between apo and holo states
for D145E (apo: 66.4 5 1.4C, holo: 65.4 5 1.6C) but different values for
WT (apo: 655 1.9C and holo: >90C) and C84Y (apo: 43.85 1.5C, holo:
66.6 5 0.8C). Shape restorations from small angle X-ray scattering were
used to evaluate conformational changes induced by the mutations. In
the apo state, an increase in the radius of gyration values upon increasing
concentrations of urea was observed for the Y5H, A31S, M103I and I148V
mutants compared to WT. Furthermore, the D145E displayed the most
affected shape compared to WT and perturbed residues were located at the
C-domain as confirmed by chemical shift perturbation analysis. In addition,
the D145E secondary structure was not significantly altered by dihedral
angles prediction from the NMR assignment data. These observations open
up new avenues for the comprehension of the complex behavior of HCM
and DCM mutations in cTnC that has heretofore been not evaluated at struc-
tural level.
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Methionine oxidation introduces methionine-aromatic interactions that play a
significant role in secondary structure conformation and stabilization. Calmod-
ulin (CaM) contains nine methionine residues that function as targets of revers-
ible oxidation, serving as a mechanism through which the cell senses and
responds to oxidative stress. Replica exchange molecular dynamics (REMD)
simulations illustrated that methionine oxidatin of the N-terminal helix of
CaM introduces two configurations that involve oxidized methionines at posi-
tions 144 and 145 interacting with tyrosine 138. As these configurations do not
occur in the unoxidized helix, we propose the conformational change is induced
by the stabilizing methionine-aromatic interaction. To verify the effect, elec-
tron paramagnetic resonance (EPR) spectroscopy performed with CaM at sub-
micromolar [Ca2þ] with probes near the residues of interest revealed two
populations in the oxidized sample and only one in the unoxidized sample,
214a Monday, February 9, 2015agreeing well with the simulation and indicating that oxidation is responsible
for a stabile conformational shift. This conformational change induced by the
noncovalent interaction between oxidized methionine and tyrosine’s aromatic
ring could be the mechanism by which CaM responds to changes in the redox
environment in a reversible manner.
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Long used as a prognostic indicator, the calcium binding protein, S100B, has
been directly linked to Malignant Melanoma (MM). S100B binds the typically
wild-type p53 tumor suppressor in MM and promotes its degradation. In order
to restore p53 levels within MM along with its tumor suppressor and apoptotic
activities, we have implemented a program for the discovery and optimization
of S100B inhibitors (often referred to as SBiXs). In the process, we have uncov-
ered and probed the three persistent binding sites within S100B. Liganding
within these sites was characterized using structural biology techniques
(NMR and X-ray crystallography) and inhibitor efficacy was evaluated using
Fluorescent Polarization Competition Assays and cellular assays. Efforts to
discover/synthesize and/or to improve existing inhibitors of S100B to restore
p53 activity in human malignant melanoma are ongoing and SBiXs occupying
the persistent binding Sites 1, 2, and 3 simultaneously are desired. Such com-
pounds can then be examined for in vivo efficacy. The compounds presented
offer potential bridging scaffolds between Sites 1, 2, and 3; and will act as
the basis for the design of improved SBiXs. SBiXs may also have therapeutic
value for treating other cancers with elevated S100B and wt p53 such as astro-
cytoma, renal tumors, and some forms of leukemia.
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In a recent scientific study, 70 new calmodulin (CaM) binding targets have been
identified in human brain.(1) For this research project, peptides corresponding
to the CaM binding portion of a number of these targets, including, LAT1,
RPS2, STIM1, CaMkv, and Rab11b, have been synthesized and purified. In
a couple of cases, including Rab 11b, the full length protein, has also been ex-
pressed and purified. The ultimate aim is to obtain an understanding of how
CaM can regulate so many targets with such selectivity. Toward this goal we
are collecting target binding data as well as structures of a range of peptides
and proteins in complex with CaM using x-ray crystallography. The peptides
described in this work have been synthesized using Fmoc solid peptide synthe-
sis and the Rab11b protein was expressed in E. Coli and purified using a series
of column chromatography steps. Crystallization conditions have been opti-
mized for a specific subset of these complexes. Diffraction data were obtained
for CaM:LAT1 at the Max Lab synchrotron facility in Lund, Sweden. The data
obtained was then refined at Colgate University, NY, employing the software,
Refmac5, to furnish a crystal structure with a resolution of 2.1 A˚ and an R-fac-
tor of 25%. We will also present preliminary binding data of the LAT1
sequence bound to CaM, determined to be in the uM range, and obtained by
isothermal titration calorimetry (ITC).
1. ‘‘Integrated protein array screening and high throughput validation of 70
novel neural calmodulin binding proteins’’ O’Connell, DJO.; Bauer, MC,
O’Brien J, Johnson, WM,* Divizio CA,* O’Kane S, Bergga˚rd T, Merino A,
A˚kerfeldt KS, Linse S, Cahill DJ Molecular & Cellular Proteomics 9, 1118-
1132 (2010).
1073-Pos Board B24
Tuning of Structure-Function Relationships by Macromolecular
Crowding
Laurel Hoffman1, Xu Wang1, Hugo Sanabria2, Margaret S. Cheung3,
John Putkey1, Neal Waxham1.
1University of Texas Health Science Center at Houston, Houston, TX, USA,
2Clemson University, Clemson, SC, USA, 3University of Houston, Houston,
TX, USA.
The cellular interior is crowded with high concentrations of macromolecules
and small organic solutes and strict maintenance of this environment, where
~30% of the total volume is occupied, is essential to cellular function. The
volume occupied by these molecules confines the 3D space in which any
particular protein can reside and is thought to modulate protein-protein inter-
actions by affecting diffusional encounter and reaction rates. In this work, weinvestigate the mechanistic consequences of crowded environments on the
structure-function relationship of the ubiquitous protein calmodulin (CaM).
CaM is highly flexible and dynamic, making it particularly susceptible to
crowded environments, and its conformational plasticity is essential for ac-
commodating binding to its 300 identified targets. We determined that
crowded environments, created with purified polymer systems and sucrose,
stabilize compact conformers of CaM, reduce translational and rotational
diffusion, modulate association and dissociation kinetics with a calmodulin-
binding target, and control rates of conformational transition. Most notably,
these effects are determined by the size and concentration of the crowding re-
agent indicating that the composition of the environment differentially tunes
CaM structure, dynamics, and target association kinetics. Our results are
shown in a general kinetic framework where there are consequences for target
selectivity and cellular signaling.
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Understanding the Structural Changes of the Calcium Binding S100A1
Protein with Molecular Dynamics Simulations
Caitlin E. Scott, Peter M. Kekenes-Huskey.
Chemistry, University of Kentucky, Lexington, KY, USA.
The S100A1 protein is ubiquitous in the human body and is particularly local-
ized to the heart and brain tissue, within which it may influence the onset of
debilitating cardiomyopathy or Alzheimer’s disease. S100A1 is a homodimer
that binds four calcium ions to drive a conformational change, whereby two he-
lices separate to expose target protein binding sites. However, the physiochem-
ical drivers of this conformational transition between the apo (no bound ions) to
the holo (bound ions) states remain unclear. To understand the atomistic basis
of conformational changes in S100A1, we performed nanosecond-scale molec-
ular dynamics simulations (MD) of the apo and holo states in explicit solvent.
These MD studies reveal a variety of conformational trends including helical
orientations, hydrogen bond contacts, and backbone fluctuations of the calcium
binding regions. In response to previous studies demonstrating that the addition
of polar functional groups to cysteine residue 85 (Cys85) increases the calcium
ions’ binding affinity, we furthermore examined the influence of glutamic acid
and glutamine mutations at site 85 (Cys85Glu/Cys85Gln) on the aforemen-
tioned conformational behavior. We finally relate structural differences be-
tween the apo and holo states for the wild-type and Cys85 mutant cases to
alterations on S100A1’s experimentally observed alterations in calcium
handling. We speculate that similar trends may emerge in similar calcium-
binding proteins.
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The ER membrane (EM) protein STIM1 is the ER Ca2þ sensor that initiates
store-operated Ca2þ entry through Orai channels in lymphocytes and many
other cells. Communication of ER Ca2þ store depletion to Orai channels in
the plasma membrane involves a transition of STIM1 dimers from an inactive
to an active state, but the conformational changes underlying this transition
remain poorly characterized. We have developed an in-vitro assay to study
the conformation and dynamics of STIM1 at the single-molecule level. Purified
STIM1 cytosolic fragments were labeled at single sites with Alexa555 and
Alexa647 by site-directed mutagenesis and cysteine-maleimide chemistry.
These served as donor and acceptor dyes for high-resolution intradimer dis-
tance measurements using single-molecule FRET. Labeled STIM1 fragments
were encapsulated in 100nm diameter, surface-immobilized liposomes and
imaged with a prism-based TIRF microscope.
We identified three broad regions within the STIM1 fragments, defined by their
characteristic FRET signatures. Within the ER-proximal N-terminal region
containing the predicted coiled-coil 1 domain (aa274-339), we observed
several transiently stable conformational states, ranging from closely apposed
(FRET ~0.8) to widely separated (FRET ~0). The different FRET states
occurred with similar probability, and transitions between them were frequent.
In the region 363-449, encompassing the CRAC activation domain (CAD), sta-
ble intermediate to high FRET values (0.6-0.9) were dominant, indicating close
apposition of paired sites in the dimer. Interestingly, low-FRET states (0.1-0.4)
were also observed at several sites, suggesting the existence of an open confor-
mation with relatively low probability. Finally, C-terminal to the CAD (aa512-
660) we found stable, broad low-FRET signals, consistent with the predicted
unstructured nature of this region. FRET ratios progressively declined from
~0.2 to 0 towards the C-terminal end, indicating increasing separation. Further
development of this approach will enable direct, high-resolution probing of
STIM1 activation under controlled conditions.
